Researcher.Life Logo

Human Gene Therapy : Impact Factor & More

eISSN: 1557-7422pISSN: 1043-0342

Key Metrics

CiteScore
8.2
Eigenfactor
0.005 - 0.01
H-Index
156
Impact Factor
< 5
SJR
Q2Genetics
SNIP
1.05
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Human Gene Therapy

Human Gene Therapy Journal Specifications

Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Human Gene Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Human Gene Therapy

Exploring Development Options of a Polishing Chromatography Step for AAV7 and AAV8.
  • 30 Dec 2025
  • Human gene therapy
In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.
  • 24 Dec 2025
  • Human gene therapy
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China.
  • 23 Dec 2025
  • Human gene therapy
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.
  • 16 Dec 2025
  • Human gene therapy
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of Neurodegeneration.
  • 16 Dec 2025
  • Human gene therapy
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD.
  • 15 Dec 2025
  • Human gene therapy
Exploring Development Options of a Polishing Chromatography Step for AAV7 and AAV8.
  • 30 Dec 2025
  • Human gene therapy
In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.
  • 24 Dec 2025
  • Human gene therapy
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China.
  • 23 Dec 2025
  • Human gene therapy
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.
  • 16 Dec 2025
  • Human gene therapy
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of Neurodegeneration.
  • 16 Dec 2025
  • Human gene therapy
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD.
  • 15 Dec 2025
  • Human gene therapy

FAQs on Human Gene Therapy